"Air pollution control residue" means unburned particles and air pollution control reactants which become entrained in the stack gases of an incinerator and which are removed and collected by air pollution control equipment.
"Antineoplastic agent" means any substance approved for human use which is produced or used to stop or reverse the growth of malignant cells.
"Biological" means a preparation made from a living organism or its products, including vaccines and cultures, intended for use in diagnosing, immunizing, or treating humans or animals or in research pertaining thereto.
"Biomedical waste" means untreated solid waste, any disposable container thereof and any reusable container thereof which has not been decontaminated, generated during the administration of medical care or the performance of medical research involving humans or animals, including infectious waste, pathological waste and chemotherapy waste, but excluding (1) any solid waste which is a hazardous waste pursuant to Section 22a-115 of the General Statutes or a radioactive material regulated pursuant to Section 22a-148 of the General Statutes; (2) untreated solid waste generated during the administration of medical care in a single or multiple family residence by a resident thereof; (3) discarded materials used for personal hygiene, such as diapers, facial tissues, and sanitary napkins, unless such materials are isolation waste; (4) syringes, hypodermic needles and other medical equipment used by farmers for the treatment of their livestock in the course of conducting farming, provided that such equipment is not excluded when used by a veterinarian or at the direction of a veterinarian; and (5) samples of biomedical waste collected and transported by Department personnel for enforcement purposes. As used in this definition of biomedical waste, the term "multiple family residence" does not include any facility specified in the definition of biomedical waste generator set forth in this section.
"Biomedical waste generator" or "generator" means any person who owns or operates a facility that produces biomedical waste in any quantity, including but not limited to the following: general hospitals, skilled nursing facilities or convalescent hospitals, intermediate care facilities, in-patient care facilities for the developmentally disabled, chronic dialysis clinics, free clinics, health maintenance organizations, surgical clinics, acute psychiatric hospitals, laboratories, medical buildings, physicians offices, veterinarians, dental offices and funeral homes.
"Biomedical waste incinerator residue" means bottom ash, air pollution control residue and other residuals of the combustion process of an incinerator utilized for the combustion of biomedical waste.
"Biomedical waste treatment facility" means a solid waste facility capable of storing, treating or disposing of any amount of biomedical waste, excluding any facility where the only biomedical waste stored, treated or disposed of is biomedical waste generated at the site where such facility is located.
"Biomedical waste transporter" or "transporter" means a person engaged in the transportation of biomedical waste by air, rail, highway, or water.
"Blood product" means any substance derived from human blood, including but not limited to plasma, platelets, red or white blood cells, and interferon.
"Body fluid" means any substance which emanates or derives from the human body, including but not limited to blood, semen, vaginal secretions, cerebrospinal fluid, synovial fluid, pleural fluid, peritoneal fluid and pericardial fluid, but excluding feces, urine, nasal secretions, sputum, sweat, tears, vomitus, saliva, and breast milk, unless any such excluded substance contains visible blood or is isolation waste.
"Bottom ash" means unburned or unburnable solid residue from incineration processes that does not become airborne.
"Central collection point" means a location, whether located on or off the generator's site, where such generator consolidates biomedical waste accumulated from original generation points before transporting it for treatment, storage, or disposal, provided that such central collection point is operated by such generator.
"C.F.R." means the Code of Federal Regulations.
"Chemotherapy waste" means waste which has come in contact with an antineoplastic agent during the preparation, handling or administration of such an agent. A container which is or has been used to contain such an agent shall be deemed chemotherapy waste even if such container is empty.
"Container" means any receptable in which material is placed. "Primary container" means the initial container in which biomedical waste is placed when multiple containers for packaging of biomedical waste are required under subsection (b) of this section. "Secondary container" means a container in which a primary container is placed.
"Decontaminate" means to substantially reduce or eliminate, by disinfection or other means, any biological hazard that is or may be associated with biomedical waste.
"Etiologic agent" means an organism defined to be an etiologic agent in 49 C.F.R. Section 173.386.
"Incinerator" means any device, apparatus, equipment or structure as defined in Sections 22a-174-1 and 22a-174-18(c) (1) of the Regulations of Connecticut State Agencies.
"Infectious agent" means any organism, such as a virus or bacterium, that is capable of being communicated by invasion and multiplication in body tissue and capable of causing disease or adverse health impacts in humans.
"Infectious waste" means waste which is capable of causing an infectious disease, is one of the wastes listed below, or is waste identified as infectious by a licensed health care provider. Waste shall be deemed capable of causing an infectious disease if there is reason to believe that it has been contaminated by an organism that is known or suspected to be pathogenic to humans and if such organism may be present in sufficient quantities and with sufficient virulence to transmit disease. The following are listed as infectious waste:
"Interment" means burial in a cemetary or burial place.
"Isolation waste" means discarded material contaminated with body fluids from (A) humans who are isolated to protect others from a highly communicable disease, and (B) animals which are isolated because they are known to be infected with an infectious agent capable of causing a highly communicable disease. A highly communicable disease is one listed in Biosafety Level 4 of the Centers for Disease Control/National Institutes of Health Guidelines entitledBiosafety in Microbiological and Biomedical Laboratories and dated May, 1988.
"Original generation point" means the location on a site where biomedical waste is generated.
"Pathological waste" means any human tissue, organ, or body part removed during surgery, autopsy or other medical procedure. Pathological waste does not include formaldehyde or other preservative agent, or a human corpse or part thereof regulated pursuant to Section 7-64 or Chapter 368i, 368j or 368k of the General Statutes.
"Publicly owned treatment works" or "POTW" means publicly owned treatment works or POTW as defined in Section 22a-430-3(a) (3) of the Regulations of Connecticut State Agencies.
"Sharp" means an item capable of causing a puncture or cut, including but not limited to a hypodermic needle, scalpel blade, and broken glassware, provided that (1) broken glassware shall not be deemed a sharp unless it is known to be contaminated with an infectious agent, and (2) a syringe, regardless whether a hypodermic needle is attached thereto, shall be deemed a sharp.
"Shipping paper" means a shipping order, bill of lading, manifest, or other shipping document as defined in 49 C.F.R. Section 171.8.
"Small quantity generator" means a biomedical waste generator that generates less than 50 pounds of biomedical waste in any calendar month or who transports, or delivers for transport, in any single shipment less than 50 pounds of biomedical waste.
"Spill" means any unplanned release, leaking, pumping, pouring, emitting, or depositing of biomedical waste or any planned release, leaking, pumping, pouring, emitting, or depositing of biomedical waste in violation of the requirements of this section.
"Storage" means the temporary holding of biomedical waste, other than temporary holding conducted in accordance with the conditions described in subparagraphs (A), (B), (C), (D), (E) and (F) of subdivision (g) (15) of this section, at any location before treating or disposing of it or transporting it for treatment, disposal, or further storage.
"Tracking form" means the tracking form described and required under subsection (h) of this section.
"Transfer" means to move, or the movement of, biomedical waste from one location on the site where such waste was generated to another location on such site.
"Transport" means to move biomedical waste by air, rail, highway, or water from the site at which such waste was generated to any other site.
"Transportation" means the act of transporting or the state of being transported.
"Transport vehicle" or "vehicle" means any conveyance used for the transportation of biomedical waste. Each cargo-carrying compartment of a vehicle, such as a truck trailer or railroad freight car, is a separate vehicle.
"Treat" means to decontaminate biomedical waste and to physically alter it so as to render it unrecognizable as biomedical waste.
"Treatment" means the act of treating or the state of being treated.
"Universal biohazard symbol" means the symbol shown in 29 C.F.R. Section 1910.145(f) (8) (ii).
"Violent mechanical stress" means tensile or compressive forces acting upon packaging material so as to cause such material to tear, rip, burst, or otherwise fail.
Conn. Agencies Regs. § 22a-209-15